Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4-, and IFN-beta-dependent
- PMID: 20404812
- PMCID: PMC2875872
- DOI: 10.1038/mi.2010.6
Control of RSV-induced lung injury by alternatively activated macrophages is IL-4R alpha-, TLR4-, and IFN-beta-dependent
Abstract
Severe respiratory syncytial virus (RSV)-induced bronchiolitis has been associated with a mixed "Th1" and "Th2" cytokine storm. We hypothesized that differentiation of "alternatively activated" macrophages (AA-M phi) would mediate the resolution of RSV-induced lung injury. RSV induced interleukin (IL)-4 and IL-13 by murine lung and peritoneal macrophages, IL-4R alpha/STAT6-dependent AA-M phi differentiation, and significantly enhanced inflammation in the lungs of IL-4R alpha(-/-) mice. Adoptive transfer of wildtype macrophages to IL-4R alpha(-/-) mice restored RSV-inducible AA-M phi phenotype and diminished lung pathology. RSV-infected Toll-like receptor (TLR)4(-/-) and interferon (IFN)-beta(-/-) macrophages and mice also failed to express AA-M phi markers, but exhibited sustained proinflammatory cytokine production (e.g., IL-12) in vitro and in vivo and epithelial damage in vivo. TLR4 signaling is required for peroxisome proliferator-activated receptor gamma expression, a DNA-binding protein that induces AA-M phi genes, whereas IFN-beta regulates IL-4, IL-13, IL-4R alpha, and IL-10 expression in response to RSV. RSV-infected cotton rats treated with a cyclooxygenase-2 inhibitor increased expression of lung AA-M phi. These data suggest new treatment strategies for RSV that promote AA-M phi differentiation.
Figures







Similar articles
-
Respiratory syncytial virus fusion protein-induced toll-like receptor 4 (TLR4) signaling is inhibited by the TLR4 antagonists Rhodobacter sphaeroides lipopolysaccharide and eritoran (E5564) and requires direct interaction with MD-2.mBio. 2012 Aug 7;3(4):e00218-12. doi: 10.1128/mBio.00218-12. Print 2012. mBio. 2012. PMID: 22872782 Free PMC article.
-
Respiratory syncytial virus impairs macrophage IFN-alpha/beta- and IFN-gamma-stimulated transcription by distinct mechanisms.Am J Respir Cell Mol Biol. 2010 Apr;42(4):404-14. doi: 10.1165/rcmb.2008-0229OC. Epub 2009 Jun 5. Am J Respir Cell Mol Biol. 2010. PMID: 19502390 Free PMC article.
-
Role of the lipoxygenase pathway in RSV-induced alternatively activated macrophages leading to resolution of lung pathology.Mucosal Immunol. 2014 May;7(3):549-57. doi: 10.1038/mi.2013.71. Epub 2013 Sep 25. Mucosal Immunol. 2014. PMID: 24064666 Free PMC article.
-
Engystol reduces onset of experimental respiratory syncytial virus-induced respiratory inflammation in mice by modulating macrophage phagocytic capacity.PLoS One. 2018 Apr 19;13(4):e0195822. doi: 10.1371/journal.pone.0195822. eCollection 2018. PLoS One. 2018. PMID: 29672626 Free PMC article.
-
Respiratory syncytial virus (RSV) evades the human adaptive immune system by skewing the Th1/Th2 cytokine balance toward increased levels of Th2 cytokines and IgE, markers of allergy--a review.Virus Genes. 2006 Oct;33(2):235-52. doi: 10.1007/s11262-006-0064-x. Virus Genes. 2006. PMID: 16972040 Review.
Cited by
-
Macrophage Polarization in Virus-Host Interactions.J Clin Cell Immunol. 2015 Apr;6(2):311. doi: 10.4172/2155-9899.1000311. J Clin Cell Immunol. 2015. PMID: 26213635 Free PMC article.
-
Regulating the adaptive immune response to respiratory virus infection.Nat Rev Immunol. 2012 Mar 9;12(4):295-305. doi: 10.1038/nri3166. Nat Rev Immunol. 2012. PMID: 22402670 Free PMC article. Review.
-
Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID-19.Allergy. 2022 Aug;77(8):2337-2354. doi: 10.1111/all.15258. Epub 2022 Feb 25. Allergy. 2022. PMID: 35174512 Free PMC article.
-
Molecular and Cellular Response to Experimental Anisakis pegreffii (Nematoda, Anisakidae) Third-Stage Larval Infection in Rats.Front Immunol. 2018 Sep 7;9:2055. doi: 10.3389/fimmu.2018.02055. eCollection 2018. Front Immunol. 2018. PMID: 30245697 Free PMC article.
-
Host Responses to Respiratory Syncytial Virus Infection.Viruses. 2023 Sep 26;15(10):1999. doi: 10.3390/v15101999. Viruses. 2023. PMID: 37896776 Free PMC article. Review.
References
-
- Welliver RC. Review of epidemiology and clinical risk factors for severe respiratory syncytial virus (RSV) infection. J. Pediatr. 2003;143:S112–S117. - PubMed
-
- Blanco JCG, Boukhvalova M, Pletneva L, Prince GA, Vogel SN. Rethinking respiratory syncytial virus vaccines. Recent Res. Devel. Experimental Med. 2004;1:75–94. Appendix 1.
-
- Boukhvalova MS, Prince GA, Soroush L, Harrigan DC, Vogel SN, Blanco JC. The TLR4 agonist, monophosphoryl lipid A, attenuates the cytokine storm associated with respiratory syncytial virus vaccine-enhanced disease. Vaccine. 2006;24:5027–5035. - PubMed
-
- Pletneva LM, Haller O, Porter DD, Prince GA, Blanco JC. Interferon-inducible Mx gene expression in cotton rats: cloning, characterization, and expression during influenza viral infection. J. Interferon Cytokine Res. 2006;26:914–921. - PubMed
-
- Kurt-Jones EA, et al. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 2000;1:398–401. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- R01 AI059775-05/AI/NIAID NIH HHS/United States
- R01 AI038985-15/AI/NIAID NIH HHS/United States
- R01 AI038985/AI/NIAID NIH HHS/United States
- R01 AI059775-04/AI/NIAID NIH HHS/United States
- R37 AI018797-26/AI/NIAID NIH HHS/United States
- AI-18797/AI/NIAID NIH HHS/United States
- AI59775/AI/NIAID NIH HHS/United States
- R37 AI018797/AI/NIAID NIH HHS/United States
- R37 AI018797-27/AI/NIAID NIH HHS/United States
- R29 AI038985/AI/NIAID NIH HHS/United States
- R01 AI018797/AI/NIAID NIH HHS/United States
- R01 AI057575/AI/NIAID NIH HHS/United States
- R56 AI018797/AI/NIAID NIH HHS/United States
- R01 AI038985-12A1/AI/NIAID NIH HHS/United States
- R01 AI038985-11/AI/NIAID NIH HHS/United States
- AI-057575/AI/NIAID NIH HHS/United States
- AI-38985/AI/NIAID NIH HHS/United States
- R01 AI057575-05/AI/NIAID NIH HHS/United States
- R01 AI057575-06A2/AI/NIAID NIH HHS/United States
- R01 AI059775/AI/NIAID NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous